Peri & Post Menopause Masterclass

In this 5-part, 9 hour masterclass series, Rhiannon takes practitioners through every aspect of managing patients experiencing menopause, from the earliest changes through to long-term management considerations. 
 
Perimenopause is a time of significant transition, and often challenge, in the lives of women and all those who have experienced menstrual cycles. All evidence now points to early, proactive and ongoing intervention as the best insurance policy for both minimisation of acute symptoms and long-term health outcomes (improved sleep & cognition and reduced all cause morbidity & mortality anyone!?).
 
Session One: Early Beginnings
We now understand the perimenopause window to last for up to a decade, beginning with initial hormone changes in the late 30's or early 40’s (for some individuals even earlier). Evidence indicates earlier intervention is associated with better navigation of this window from both a symptom perspective and for improved long-term health outcomes. This session includes a review of premature ovarian insufficiency/failure (historically termed premature menopause).
 
Session Two: The Turbulent Years
The acute window of perimenopause usually lasts for a couple of years, characterised by hormonal fluctuations, often resulting in significant shifts in symptomatology. Hot flushes, significant mood lability, depression & anxiety, migraines, menstrual cycle irregularity, heavy menstrual bleeding, cognition challenges and insomnia are all characteristic of this time.
 
Extra Content: Menopausal Migraines.
Specific considerations for migraine management in both peri and post menopause, including hormone and histamine considerations. 
 
Session Three: Long Term Management
In the postmenopausal years women and all those who have menstruated are best assured of positive long term health outcomes if particular attention is paid to risk mitigation in regards to bone, cardiovascular, adrenal, metabolic and brain health. This session includes a full breakdown of menopausal hormone therapy (MHT).
 
Extra Content: Adrenals, Androgens & Metabolic considerations. 
A focus on adrenal, androgen and metabolic considerations for peri and post menopause, including influences on progesterone. 
 
On completion of this course practitioners will be confident in:
🌟 Hormone pathology assessment: from markers of early changes, to perimenopause fluctuations, through to the post menopausal picture.
🌟 Identifying markers in general pathology indicative of long term risk for bone density issues.
🌟 Identifying clinical signs & symptoms that act as early indicators of pending change & long term risk.
🌟 Key clinical strategies for optimising hormones through perimenopause.
🌟 Supporting patients before they're even aware symptoms may be related to perimenopause changes.
🌟 Implementing the most effective interventions for symptom management including hot flushes, mood changes, insomnia, libido issues, migraines, heavy menstrual bleeding (HMB), cognition challenges & genitourinary symptoms.
🌟 Clinical strategies for assessing & optimising metabolic, cardiovascular, bone, brain, thyroid and adrenal health specific to perimenopause and beyond.
🌟  Safety, contraindications & benefits of soy isoflavones prescription. 
🌟 Understanding menopausal hormone therapy (MHT), including safety, indications, efficacy, forms and safe & effective coprescription of herbal & nutritional medicines.